Efficacy of autologous stem cell therapy in femoral head avascular necrosis: a comparative study.
Avascular necrosis
Femoral head
HHS
Stem cell implantation
Total hip arthroplasty
VAS
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
24 Oct 2023
24 Oct 2023
Historique:
received:
27
08
2023
accepted:
17
10
2023
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
24
10
2023
Statut:
epublish
Résumé
Avascular necrosis of the femoral head is a disease usually seen in middle-aged individuals. Although many aetiological factors have been blamed, there are still aetiological factors that have not been fully elucidated. Although treatment options show a wide range, early and appropriate treatment is of great importance to preserve the hip joint. In our study, we compared the results of core decompression and core decompression combined with bone marrow mesenchymal stem cell implantation in patients with avascular necrosis of the femoral head. In this retrospective study, Steinberg stage 1-2 patients operated on for avascular necrosis of the femoral head between 2018 and 2023 were analysed. Separate groups were formed from patients who underwent isolated core decompression and core decompression + bone marrow mesenchymal stem cell implantation. Age, gender, Steinberg staging, aetiology of the disease, follow-up period, progression to hip arthroplasty, Vas scores, Harris hip scores (HHS), and complications were evaluated. Harris hip scores at preoperative and 2-year follow-up periods; VAS scores at preoperative, 3-month, 6-month, 1-year, and 2-year follow-up periods were analysed. In the study, 44 patients were analysed. While 25 patients underwent core decompression only (group 1), 19 patients underwent core decompression and bone marrow mesenchymal stem cell implantation (group 2). The mean age of the patients in group 1 was 39.3 ± 6.5 years, and the mean age of the patients in group 2 was 38.4 ± 6.7 years. The mean follow-up was 31.85 ± 4.4 months in group 1 and 32.2 ± 4.1 months in group 2. Total hip arthroplasty was performed in 2 of the patients in group 1 (one of the patients underwent total hip arthroplasty at month 28 and the other at month 33). The treatment of avascular necrosis of the femoral head varies according to various staging methods. Early diagnosis of the disease and correct treatment are very important for the patient's quality of life in the future. In our research, we found that patients who received both core decompression and stem cell implantation for early-stage avascular necrosis of the femoral head exhibited decreased pain at the 6-month, 1-year, and 2-year follow-up examinations. Additionally, their hip function improved at the 24-month mark according to the HHS evaluation.
Identifiants
pubmed: 37875891
doi: 10.1186/s13018-023-04297-0
pii: 10.1186/s13018-023-04297-0
pmc: PMC10598958
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
799Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Lau RL, Perruccio AV, Evans HM, Mahomed SR, Mahomed NN, Gandhi R. Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a systematic review. BMC Musculoskelet Disord. 2014;15:1–10. https://doi.org/10.1186/1471-2474-15-156 .
doi: 10.1186/1471-2474-15-156
Mont MA, Marulanda GA, Jones LC, Saleh KJ, Gordon N, Hungerford DS, Steinberg ME. Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Jt Surg Am. 2006;88:16–26.
Karatoprak Ö, Korkmaz MF, Kara AN, Göğüş A, Işıklar ZU. Early results of autologous mononuclear bone marrow cell implantation in nontraumatic avascular necrosis of the femoral head. Acta Orthop Traumatol Turc. 2008;42:178–83.
doi: 10.3944/AOTT.2008.178
pubmed: 18716432
Yan ZQ, Chen YS, Li WJ, et al. Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol. 2006;9(1):3–7.
pubmed: 16393508
Liang D, Pei J, Zhang X, Chen X. Clinical outcomes of autologous platelet-rich plasma and bone marrow mononuclear cells grafting combined with core decompression for Association Research Circulation Osseous II–IIIA stage non-traumatic osteonecrosis of the femoral head. Int Orthop. 2023. https://doi.org/10.1007/s00264-023-05779-w .
doi: 10.1007/s00264-023-05779-w
pubmed: 37964157
Song WS, Yoo JJ, Kim Y-M, Kim HJ. Results of multiple drilling compared with those of conventional methods of core decompression. Clin Orthop Relat Res. 2007;454:139–46.
doi: 10.1097/01.blo.0000229342.96103.73
pubmed: 16906081
Kang JS, Suh YJ, Moon KH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018;9:1–9. https://doi.org/10.1186/s13287-018-1030-y .
doi: 10.1186/s13287-018-1030-y
Koo KH, Kim R, Ko GH, Song HR, Yeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head. A randomized clinical trial of core decompression. J Bone Jt Surg. 1995;77(B):870–4.
doi: 10.1302/0301-620X.77B6.7593097
Steinberg ME, Hayken G, Steinberg D. A quantitative system for staging avascular necrosis. J Bone Jt Surg Br Vol. 1995;77:34–41.
doi: 10.1302/0301-620X.77B1.7822393
Atilla B, Bakırcıoğlu S, Shope AJ, Parvızı J. Joint-preserving procedures for osteonecrosis of the femoral head. EFORT Open Rev. 2020;4(12):647–58. https://doi.org/10.1302/2058-5241.4.180073.PMID:32010453;PMCID:PMC6986391 .
doi: 10.1302/2058-5241.4.180073.PMID:32010453;PMCID:PMC6986391
pubmed: 32010453
pmcid: 6986391
Goodman SB. The biological basis for concentrated iliac crest aspirate to enhance core decompression in the treatment of osteonecrosis. Int Orthop. 2018;42(7):1705–9. https://doi.org/10.1007/s00264-018-3830-1 .
doi: 10.1007/s00264-018-3830-1
pubmed: 29435623
Hernigou P, Dubory A, Homma Y, Guissou I, Flouzat Lachaniette CH, Chevallier N, Rouard H. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42(7):1639–49. https://doi.org/10.1007/s00264-018-3941-8 .
doi: 10.1007/s00264-018-3941-8
pubmed: 29744647
Li M, Ma Y, Fu G, Zhang R, Li Q, Deng Z, Zheng M, Zheng Q. 10-year follow-up results of the prospective, double-blinded, randomized, controlled study on autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of the femoral head. Stem Cell Res Ther. 2020;11(1):287. https://doi.org/10.1186/s13287-020-01810-8.PMID:32678055;PMCID:PMC7364559 .
doi: 10.1186/s13287-020-01810-8.PMID:32678055;PMCID:PMC7364559
pubmed: 32678055
pmcid: 7364559
Pierce TP, Jauregui JJ, Elmallah RK, Lavernia CJ, Mont MA, Nace J. A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8:228–32. https://doi.org/10.1007/s12178-015-9280-0 .
doi: 10.1007/s12178-015-9280-0
pubmed: 26045085
pmcid: 4596206
Al-Omari AA, Aleshawi AJ, Marei OA, et al. Avascular necrosis of the femoral head after single steroid intra-articular injection. Eur J Orthop Surg Traumatol. 2020;30:193–7. https://doi.org/10.1007/s00590-019-02555-8 .
doi: 10.1007/s00590-019-02555-8
pubmed: 31538269
Mont MA, Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res (1976–2007). 2004;429:131–138. https://doi.org/10.1097/01.blo.0000150128.57777.8e
Steinberg ME, Brighton CT, Corces A, et al. Osteonecrosis of the femoral head: results of core decompression and grafting with and without electrical stimulation. Clin Orthop Relat Res (1976–2007). 1989;249:199–208.
Plakseychuk AY, Kim S-Y, Park B-C, Varitimidis SE, Rubash HE, Sotereanos DG. Vascularized compared with nonvascularized fibular grafting for the treatment of osteonecrosis of the femoral head. JBJS. 2003;85:589–96. https://doi.org/10.2106/00004623-200304000-00001 .
doi: 10.2106/00004623-200304000-00001
Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clin Orthop Relat Res. 2008;466:1093–103. https://doi.org/10.1007/s11999-008-0184-9 .
doi: 10.1007/s11999-008-0184-9
pubmed: 18392909
pmcid: 2311489
Lim YW, Kim YS, Lee JW, Kwon SY. Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med. 2013;45:e61–e61. https://doi.org/10.1038/emm.2013.128 .
doi: 10.1038/emm.2013.128
pubmed: 24232260
pmcid: 3849575
Gangji V, De Maertelaer V, Hauzeur J-P. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49:1005–9. https://doi.org/10.1016/j.bone.2011.07.032 .
doi: 10.1016/j.bone.2011.07.032
pubmed: 21821156
Wang B-L, Sun W, Shi Z-C, et al. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg. 2010;130:859–65. https://doi.org/10.1007/s00402-009-0939-0 .
doi: 10.1007/s00402-009-0939-0
pubmed: 19621230
Wakefield SM, Giannoudis PV, Wakefield SMM. Rare bi-focal presentation of avascular necrosis of the femoral head: successful targeted treatment as per the diamond concept and review of the literature. Cureus. 2023. https://doi.org/10.7759/cureus.36423 .
doi: 10.7759/cureus.36423
pubmed: 37605668
pmcid: 10440144
Lavernia CJ, Alcerro JC, Rossi MD. Fear in arthroplasty surgery: the role of race. Clin Orthop Relat Res. 2010;468:547–54. https://doi.org/10.1007/s11999-009-1101-6 .
doi: 10.1007/s11999-009-1101-6
pubmed: 19763716
Nagai K, Ikutomo H, Yamada M, Tsuboyama T, Masuhara K. Fear of falling during activities of daily living after total hip arthroplasty in Japanese women: a cross-sectional study. Physiotherapy. 2014;100:325–30. https://doi.org/10.1016/j.physio.2013.10.006 .
doi: 10.1016/j.physio.2013.10.006
pubmed: 24602831